A method for stimulating a immune response against IL-13Rα2 in a subject having or at risk for developing a disease having cells expressing IL-13Rα2 includes the steps of formulating the anti-cancer vaccine outside of the subject and administering the vaccine to the subject in an amount sufficient...http://www.google.com/patents/US7960361?utm_source=gb-gplus-sharePatent US7960361 - Nucleic acid cancer immunotherapy
